newsfilter
← Latest News
Business Wire·

CEL-SCI Announces Pricing of Public Offering

CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE:CVM), a clinical stage cancer immunotherapy company, today announced the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a